FOUNDER

Charles is the inventor of the BioTusk™ system and the driving force behind its revolutionary approach to oral–systemic oxidative therapy.

FOUNDER

Don brings deep expertise in legal strategy, regulatory interpretation, and risk frameworks essential to advancing BioTusk™ toward commercial readiness

Chief Financial Officer

Jeff guides BioTusk’s financial strategy and organizational development, ensuring disciplined planning and investor-ready execution. He bridges scientific innovation with sound financial stewardship to support the company’s clinical, regulatory, and commercial growth.